Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Coronary heart disease risk"

Article category

Keywords

Publication year

"Coronary heart disease risk"

Original Article

Background/Aims

A close relationship has been established between nonalcoholic fatty liver disease (NAFLD) and an elevated risk of coronary heart disease (CHD), but little is known about the association between alcoholic fatty liver disease (AFLD) and CHD risk. The aim of this study was to determine whether AFLD is associated with elevated CHD risk.

Methods

We retrospectively enrolled 10,710 subjects out of 11,469 individuals who visited the Konkuk University Health Care Center for a routine health checkup in 2010. AFLD was diagnosed made when the usual amount of alcohol consumption exceeded 210 g/week in males and 140 g/week in females for the previous 2 years and when hepatic steatosis was detected by liver ultrasonography. The 10-year risk for CHD was estimated using the Framingham Risk Score.

Results

Hepatic steatosis was diagnosed in 4,142 of the 10,710 individuals (38.7%); the remainder (i.e., n=6,568) became the control group. The 4,142 individuals with hepatic steatosis were divided into two groups: NAFLD (n=2,953) and AFLD (n=1,189). The risk of CHD was higher in AFLD (6.72±0.12) than in the control group (5.50±0.04, P<0.001), and comparable to that in NAFLD (7.32±0.07, P=0.02).

Conclusions

Individuals with AFLD have an elevated 10-year risk of CHD that is comparable to those with NAFLD. Therefore, AFLD should be considered a significant risk for future CHD, and preventive measures should be considered earlier.

Citations

Citations to this article as recorded by  Crossref logo
  • Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
    Steven R. Horbal, Patrick X. Belancourt, Peng Zhang, Sven A. Holcombe, Sameer Saini, Stewart C. Wang, Anne E. Sales, Grace L. Su
    Digestive Diseases and Sciences.2024; 69(7): 2681.     CrossRef
  • Shear wave elastography to evaluate carotid artery elasticity in long‐term drinkers with varying degrees of alcoholic fatty liver disease
    Xiya Li, Zhen Li, Mengmeng Zhang, Guangsen Li, Tingting Yu
    Journal of Clinical Ultrasound.2023; 51(4): 696.     CrossRef
  • 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
    Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui,
    Clinical Gastroenterology and Hepatology.2022; 20(12): 2809.     CrossRef
  • Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
    Undurti N. Das
    Journal of Advanced Research.2019; 17: 17.     CrossRef
  • Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
    Caroline E Geisler, Benjamin J Renquist
    Journal of Endocrinology.2017; 234(1): R1.     CrossRef
  • The Frequency of Alcohol Use in Iranian Urban Population: The Results of a National Network Scale Up Survey
    Ali Nikfarjam, Saiedeh Hajimaghsoudi, Azam Rastegari, Ali Akbar Haghdoost, Abbas Ali Nasehi, Nadereh Memaryan, Terme Tarjoman, Mohammad Reza Baneshi
    International Journal of Health Policy and Management.2016; 6(2): 97.     CrossRef
  • Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
    Dong Hyun Sinn, Yong-Han Paik
    Clinical and Molecular Hepatology.2014; 20(2): 151.     CrossRef
  • 12,792 View
  • 83 Download
  • 7 Web of Science
  • Crossref